Page last updated: 2024-08-24

aripiprazole and ADDH

aripiprazole has been researched along with ADDH in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (29.73)	29.6817
2010's	22 (59.46)	24.3611
2020's	4 (10.81)	2.80

Authors

Authors	Studies
Lee, MC; Lin, JW; Tsai, LH	1
Arango, C; Cabras, A; Cortese, S; Fusar-Poli, P; Hernández, P; Moreno, C; Parellada, M; Pastor Jordá, C; Salazar de Pablo, G; Santosh, P; Simonoff, E; Vaquerizo-Serrano, J; Veenstra-VanderWeele, J	1
Campos, AC; Costa, KCM; Crippa, ACS; Crippa, JAS; Del-Bel, EA; Ferreira, FR; Guimarães, FS; Hallak, JEC; Lima, DA; Pedrazzi, JFC; Silva-Amaral, D; Zuardi, AW	1
Fukuda, KI; Kasahara, S; Kato, Y; Matsudaira, K; Niwa, SI; Sato, N; Takahashi, K; Toyofuku, A; Uchida, K; Yoshikawa, T	1
Han, TH; Kim, DY; Moon, JH; Park, DW	1
Binici, NC; Güney, SA	1
Abaei, A; Boeckers, TM; Fegert, JM; Hengerer, B; Nespoli, E; Rasche, V; Rizzo, F	1
Naguy, A	1
Anagnostou, E	1
Fu, AT; Pan, PY; Yeh, CB	1
Fujio, M; Hamamoto, Y; Kano, Y; Kono, T; Matsuda, N; Nonaka, M	1
Ghanizadeh, A	1
Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O	1
Párraga, HC; Sherman, BC	1
Accordino, RE; Henry, CA; Kidd, C; McDougle, CJ; Politte, LC	1
Alosi, N; Cucinotta, F; Di Rosa, G; Gagliano, A; Germanò, E; Italiano, D; Lamberti, M; Siracusano, R; Spina, E	1
Bruhn, CH; Fink-Jensen, A; Jakobsen, KD; Nielsen, J; Pagsberg, AK	1
Findling, RL	1
Demeter, CA; Findling, RL; Leskovec, T; McNamara, NK; Short, EJ; Stansbrey, RJ; Townsend, LD	1
Budman, C; Coffey, BJ; Schrock, M; Shechter, R; Simon, E; Spirgel, A; Wieland, N	1
Ketzer, CR; Narvaez, J; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP	1
Ketzer, CR; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP	1
Carbray, MJ; McGuinness, T	1
Barnett, RJ; Cauble, S; McLaren, JL	1
Appel, DI; Markowitz, JS; Peterson, YK; Wang, Z; Zhu, HJ	1
Chen, VC; Chou, JY; Robson, D; Yu, SH	1
Carson, WH; Forbes, RA; Mankoski, R; Mathew, SJ; Zhao, J	1
Calabrese, JR; Demeter, CA; Findling, RL; Frazier, TW; Lingler, J; McNamara, NK; Otto, BD; Rowles, BM; Stansbrey, RJ; Youngstrom, EA	1
Cavanna, AE; Rickards, H; Worrall, R	1
Berloffa, S; Calarese, T; Cedro, C; Gagliano, A; Ilardo, G; Magazù, A; Masi, G; Pfanner, C; Siracusano, R	1
Coffey, DB; John, N; Potter, PO	1
Stern, AP; Trieu, ML	1
Aubry, JM; Bertschy, G; Bryois, C; Eliez, S; Etter, M; Nanzer, N	1
Demb, H; Valicenti-McDermott, MR	1
Aleardi, M; Biederman, J; Doyle, R; Hammerness, P; Joshi, G; Kotarski, M; Mick, E; Spencer, T; Wozniak, J	1
de Souza, CK; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP	1
Kikukawa, S	1

Reviews

7 review(s) available for aripiprazole and ADDH

Article	Year
Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response. Journal of the American Academy of Child and Adolescent Psychiatry, 2023, Volume: 62, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Humans; Risperidone	2023
Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology, 2022, Volume: 239, Issue:9 Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Cannabidiol; Child, Preschool; Endocannabinoids; Humans	2022
Clinical trials in autism spectrum disorder: evidence, challenges and future directions. Current opinion in neurology, 2018, Volume: 31, Issue:2 Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders	2018
Systematic review of clinical trials of aripiprazole for treating attention deficit hyperactivity disorder. Neurosciences (Riyadh, Saudi Arabia), 2013, Volume: 18, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Humans; Piperazines; Quinolones	2013
Psychopharmacological interventions in autism spectrum disorder. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:7 Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Humans; Irritable Mood; Psychotropic Drugs; Risperidone; Stereotyped Behavior	2016
Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. The Journal of clinical psychiatry, 2008, Volume: 69 Suppl 4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Dibenzothiazepines; Disorders of Excessive Somnolence; Headache; Humans; Methylphenidate; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone	2008
[Psychiatry]. Revue medicale suisse, 2005, Jan-12, Volume: 1, Issue:2 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Humans; Lamotrigine; Mental Disorders; Methylphenidate; Piperazines; Quinolones; Risperidone; Triazines	2005

Trials

10 trial(s) available for aripiprazole and ADDH

Article	Year
Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study. Journal of child and adolescent psychopharmacology, 2018, Volume: 28, Issue:10 Topics: Adolescent; Antidepressive Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Neuropsychological Tests	2018
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study. Paediatric drugs, 2016, Volume: 18, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Female; Humans; Male; Pilot Projects; Risperidone	2016
Aripiprazole in children with attention-deficit/hyperactivity disorder. Journal of child and adolescent psychopharmacology, 2008, Volume: 18, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Child; Cognition; Dose-Response Relationship, Drug; Female; Headache; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Treatment Outcome	2008
Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial. The Journal of clinical psychiatry, 2009, Apr-21, Volume: 70, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Pilot Projects; Piperazines; Quinolones; Surveys and Questionnaires	2009
Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Piperazines; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index	2009
Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study. Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inpatients; Male; Outpatients; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Time Factors; Treatment Outcome	2011
An open-label study of aripiprazole in children with a bipolar disorder. Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Outpatients; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Weight Gain	2011
Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:2 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Child; Female; Humans; Logistic Models; Male; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Severity of Illness Index; Tourette Syndrome; Treatment Outcome	2012
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS spectrums, 2007, Volume: 12, Issue:9 Topics: Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Brief Psychiatric Rating Scale; Child; Drug Tolerance; Female; Humans; Male; Piperazines; Quinolones; Surveys and Questionnaires	2007
Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial. CNS spectrums, 2007, Volume: 12, Issue:10 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Double-Blind Method; Female; Humans; Male; Piperazines; Quinolones	2007

Other Studies

20 other study(ies) available for aripiprazole and ADDH

Article	Year
Social Communication Disorder in an Adolescent with ADHD and Tourette's Disorder Treated with Aripiprazole. Psychiatria Danubina, 2022,Spring, Volume: 34, Issue:1 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Humans; Social Communication Disorder; Tourette Syndrome	2022
Diagnosis and treatment of intractable idiopathic orofacial pain with attention-deficit/hyperactivity disorder. Scientific reports, 2023, 01-30, Volume: 13, Issue:1 Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Chronic Pain; Facial Pain; Humans; Retrospective Studies	2023
Transient Isolated Lower Bulbar Palsy With Elevated Serum Anti-GM1 and Anti-GD1b Antibodies During Aripiprazole Treatment. Pediatric neurology, 2017, Volume: 66 Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bulbar Palsy, Progressive; Child; G(M1) Ganglioside; Gangliosides; Humans; Immunoglobulin G; Male; Psychotropic Drugs	2017
Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis. Journal of child and adolescent psychopharmacology, 2017, Volume: 27, Issue:8 Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Epistaxis; Humans; Male; Mood Disorders; Risperidone	2017
Aripiprazole and Riluzole treatment alters behavior and neurometabolites in young ADHD rats: a longitudinal Translational psychiatry, 2017, 08-01, Volume: 7, Issue:8 Topics: Animals; Antipsychotic Agents; Aripiprazole; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Brain; Disease Models, Animal; Glutamic Acid; Magnetic Resonance Spectroscopy; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Inbred WKY; Riluzole	2017
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD. The Journal of nervous and mental disease, 2017, Volume: 205, Issue:9 Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome	2017
Expert consensus on pharmacotherapy for tic disorders in Japan. Brain & development, 2019, Volume: 41, Issue:6 Topics: Adult; Aged; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Comorbidity; Consensus; Drug Therapy; Expert Testimony; Female; Health Knowledge, Attitudes, Practice; Humans; Japan; Male; Middle Aged; Physicians; Risperidone; Surveys and Questionnaires; Tic Disorders; Tics; Tourette Syndrome	2019
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation. Therapeutic drug monitoring, 2015, Volume: 37, Issue:3 Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline	2015
Acute Dystonia After Stimulant Discontinuation in 2 ADHD Children Receiving Aripiprazole. Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:4 Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dystonia; Female; Humans; Male; Withholding Treatment	2015
Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole. Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Databases, Factual; Denmark; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Neurodevelopmental Disorders; Obsessive-Compulsive Disorder; Psychotic Disorders; Schizophrenia; Tourette Syndrome	2016
Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. Journal of child and adolescent psychopharmacology, 2008, Volume: 18, Issue:5 Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies; Severity of Illness Index; Tourette Syndrome; Treatment Outcome	2008
Pediatric bipolar disorder. Journal of psychosocial nursing and mental health services, 2009, Volume: 47, Issue:12 Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Child Psychiatry; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Carbonate; Nursing Assessment; Parents; Patient Education as Topic; Piperazines; Psychiatric Nursing; Psychotherapy; Quinolones; Risperidone; Social Support	2009
Aripiprazole induced acute dystonia after discontinuation of a stimulant medication. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1 Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Drug Administration Schedule; Dystonia; Humans; Male; Methylphenidate; Piperazines; Quinolones; Substance Withdrawal Syndrome	2010
Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions. Toxicology, 2010, Apr-11, Volume: 270, Issue:2-3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Carboxylic Ester Hydrolases; Central Nervous System Stimulants; Cluster Analysis; Drug Evaluation, Preclinical; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Humans; Hydrolysis; Inactivation, Metabolic; Male; Methylphenidate; Mice; Models, Molecular; Piperazines; Quinolones	2010
Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Oct-01, Volume: 34, Issue:7 Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Humans; Male; Piperazines; Propylamines; Quinolones; Tic Disorders	2010
Treatment practices in Tourette syndrome: the European perspective. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome	2012
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:5 Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment	2012
A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Blood Glucose; Diabetes Mellitus, Type 1; Hospitalization; Humans; Hyperglycemia; Language Disorders; Learning Disabilities; Male; Piperazines; Quinolones; Risperidone	2012
Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5 Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Mass Index; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Drug Approval; Female; Follow-Up Studies; Humans; Impulsive Behavior; Intellectual Disability; Male; Mood Disorders; Piperazines; Quinolones; Reactive Attachment Disorder; Self-Injurious Behavior; Sleep Wake Disorders	2006
Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome. The international journal of neuropsychopharmacology, 2008, Volume: 11, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Female; Humans; Piperazines; Quinolones; Restless Legs Syndrome	2008